Johnsen S G
Acta Endocrinol (Copenh). 1978 Dec;89(4):763-9. doi: 10.1530/acta.0.0890763.
In a long-term hypophysectomized male HCG treatment was unable to initiate spermatogenesis. However, a spermatogenesis induced by HMG/HCG treatment could be maintained by HCG alone for 7 years with clinical fertility. In another hypogonadotrophic male HCG was also unable to initiate spermatogenesis. But a spermatogenesis once induced by HMG/HCG treatment could be maintained for more than one year with HCG alone. It is suggested that gonadotrophin treatment of the hypogonadotrophic male should consist of HMG + HCG until complete spermatogenesis is induced followed by maintenance treatment with HCG.
在长期垂体切除的雄性大鼠中,人绒毛膜促性腺激素(HCG)治疗无法启动精子发生。然而,由人绝经期促性腺激素(HMG)/HCG治疗诱导的精子发生可以仅用HCG维持7年,并具有临床生育能力。在另一只性腺功能减退的雄性大鼠中,HCG也无法启动精子发生。但是,一旦由HMG/HCG治疗诱导的精子发生可以仅用HCG维持一年以上。建议对性腺功能减退的雄性大鼠进行促性腺激素治疗时,应先使用HMG + HCG,直到诱导出完全的精子发生,然后用HCG进行维持治疗。